Drug discovery in the 21st century is undergoing the most dramatic change it has ever seen. Pharma companies are globalizing their R&D capabilities, seeking new collaboration partners and outsourcing activities from simple tasks to complete projects. And everyone in pharma, biotechs, CROs and academic research institutes is seeking new and better approaches to discovering new drug candidates.
